Latest News & Features
Americas
A US federal court has upheld a preliminary injunction against a Chinese doctor accused of stealing trade secrets from US heart device manufacturer AtriCure. 26 January 2021
Africa
Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations. 25 January 2021
Big Pharma
A subsidiary of MSD has failed to revive a record $2.5bn verdict against Gilead Sciences, after the US Supreme Court refused to hear arguments that a patent was improperly invalidated. 21 January 2021
Americas
3M has secured an injunction against a Florida company it has accused of selling more than 10,000 counterfeit versions of its N95 face masks at the US District Court for the District of Minnesota. 21 January 2021
Big Pharma
Illumina has secured a victory in its patent dispute with Chinese genome sequencing company BGI at the English High Court, which ruled that four of its patents had been infringed. 21 January 2021
Americas
The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator. 21 January 2021
Americas
The US International Trade Commission is to investigate allegations that a Chinese company infringed patents held by Ventria Bioscience by importing genetically-engineered rice seeds for medical purposes. 19 January 2021
Americas
Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device. 18 January 2021
Americas
US customs officials at John F Kennedy International Airport in New York have seized 100,000 counterfeit 3M N95 masks imported from Hong Kong. 18 January 2021
Americas
Allergan should not be permitted to immediately appeal against a recent ruling which requires it to face allegations that it monopolised the pricing of dementia drugs, according to a New York-based patent attorney. 18 January 2021